Fagron Compounding Services recalls norepinephrine Bitartrate
- Recalling company
- Fagron Compounding Services
- Product
- norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02
- Reason
- Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Mar 20, 2026
- Reported
- Apr 15, 2026
- Distribution
- Nationwide in the U.S.A.
- Status
- Ongoing
- Quantity
- 5140 bags
- Lot / codes
- Lot: C274-000050004, Exp.: 4/24/2026; C274-000050295, Exp.:5/8/2026; C274-000050773, Exp.: 6/4/2026; C274-000051219, Exp.: 6/21/2026; C274-000051318, Exp.: 6/27/2026; C274-000051602, Exp.: 7/12/2026.
- Company location
- Wichita, KS
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0439-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0439-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.